Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended SeptemberJune 30, 20222023

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to __________

Commission file number 000-53851

Mobivity Holdings Corp.

(Exact Name of Registrant as Specified in Its Charter)

Nevada

26-3439095

(State or Other Jurisdiction of

(I.R.S. Employer

Incorporation or Organization)

Identification No.)

3133 West Frye Road, # 215

Chandler, Arizona85226

(Address of Principal Executive Offices)

(877)282-7660

(Registrant’s Telephone Number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

None

None

None

None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of NovemberAugust 14, 2022,2023, the registrant had 61,311,15567,292,393 shares of common stock, par value $0.001 per share, issued and outstanding.

MOBIVITY HOLDINGS CORP.

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION

1

Item 1. Financial Statements

1

Condensed Consolidated Balance Sheets

1

Condensed Consolidated Statements of Operations and Comprehensive Loss

2

Condensed Consolidated Statement of Stockholders’ Equity (Deficit)Deficit

3

Condensed Consolidated Statements of Cash Flows

4

Notes to Condensed Consolidated Financial Statements

5

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

18

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

19

24

Item 4. Controls and Procedures.

19

24

PART II – OTHER INFORMATION

20

25
Item 1. Legal Proceedings2025
Item 1A. Risk Factors2025
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds2025
Item 3. Defaults Upon Senior Securities2025
Item 4. Mine Safety Disclosures2025
Item 5. Other Information2025

Item 6. Exhibits

20

26

SIGNATURES

21

27


Table of Contents

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

Mobivity Holdings Corp.

Condensed Consolidated Balance Sheets

 

September 30,

 

December 31,

  June 30, December 31, 
 

2022

 

2021

  2023  2022 
 

(Unaudited)

 

(Audited)

  (Unaudited) (Audited) 

ASSETS

            

Current assets

            

Cash

 $1,016,745  $735,424  $529,471  $426,740 

Accounts receivable, net of allowance for doubtful accounts $59,190 and $56,340, respectively

 869,965  578,303 
Accounts receivable, net of allowance for doubtful accounts $9,423 and $34,446, respectively  542,711   1,081,183 

Other current assets

  252,504   227,458   423,371   195,017 

Total current assets

 2,139,214  1,541,185   1,495,553   1,702,940 

Goodwill

 411,183  411,183 

Right to use lease assets

 1,032,132  1,187,537   878,380   981,896 

Intangible assets, net

 584,369  1,124,720 
Intangible assets and software development costs, net  99,257   194,772 

Other assets

  153,756   173,325   127,417   137,917 

TOTAL ASSETS

 $4,320,654  $4,437,950  $2,600,607  $3,017,525 

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

    
LIABILITIES AND STOCKHOLDERS’ DEFICIT        

Current liabilities

            

Accounts payable

 $3,636,629  $3,823,909  $3,481,685  $3,412,612 

Accrued interest

 443,448  172,239   442,269   443,448 

Accrued and deferred personnel compensation

 298,316  495,533   297,572   569,347 

Deferred revenue and customer deposits

 613,997  377,170   469,750   902,727 

Related party notes payable, net - current maturities

 1,812,500  819,531   1,361,250   2,711,171 

Notes payable, net - current maturities

 35,875  69,052   18,096   32,617 

Operating lease liability

 245,816  229,240 
Operating lease liability, current  263,663   251,665 

Other current liabilities

  142,238   9,071   15,162   49,541 

Total current liabilities

 7,228,819  5,995,745   6,349,447   8,373,128 
         

Non-current liabilities

            

Related party notes payable, net - long term

 2,315,607  2,498,711   3,894,345   2,481,290 

Notes payable, net - long term

 36,666  39,086   30,223   31,092 

Operating lease liability

  1,001,579   1,188,589   801,492   936,924 

Total non-current liabilities

  3,353,852   3,726,386   4,726,060   3,449,306 

Total liabilities

 10,582,671  9,722,131   11,075,507   11,822,434 
         

Stockholders' equity (deficit)

    

Common stock, $0.001 par value; 100,000,000 shares authorized; 61,311,155 and 55,410,695, shares issued and outstanding

 61,311  55,411 
Stockholders’ deficit        
Common stock, $0.001 par value; 100,000,000 shares authorized; 65,797,567 and 61,311,155, shares issued and outstanding  65,798   61,311 

Equity payable

 100,862  100,862   307,318   324,799 

Additional paid-in capital

 108,273,597  102,446,921   113,868,248   108,806,353 

Accumulated other comprehensive income (loss)

 (128,950) (52,088)
Accumulated other comprehensive loss  (69,598)  (100,963)

Accumulated deficit

  (114,568,837)  (107,835,287)  (122,646,666)  (117,896,409)

Total stockholders' equity (deficit)

  (6,262,017)  (5,284,181)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

 $4,320,654  $4,437,950 
Total stockholders’ deficit  (8,474,900)  (8,804,909)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $2,600,607  $3,017,525 

See accompanying notes to consolidated financial statements.

1
Table of Contents

1

Mobivity Holdings Corp.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 2023  2022  2023  2022 
 

Three Months Ended

 

Nine Months Ended

  Three Months Ended Six Months Ended 
 

September 30,

 

September 30,

  June 30,  June 30, 
 

2022

 

2021

 

2022

 

2021

  2023  2022  2023  2022 

Revenues

                 

Revenues

 $1,890,437  $2,311,548  $5,787,168  $7,561,966  $1,861,171  $1,867,162  $3,742,653  $3,896,731 

Cost of revenues

  1,806,022   1,008,703  $4,183,719   3,322,639   1,371,206   1,202,749  $2,437,781   2,377,697 

Gross profit

 84,415  1,302,845  1,603,449  4,239,327   489,965   664,413   1,304,872   1,519,034 
                 

Operating expenses

                        

General and administrative

 983,428  1,245,085  3,088,588  3,491,855   1,071,153   897,984   2,615,259   2,105,160 

Sales and marketing

 614,600  978,968  1,778,371  2,987,411   602,911   566,270   1,294,131   1,163,771 

Engineering, research, and development

 784,804  678,209  2,360,863  2,076,194   804,343   873,836   1,538,718   1,576,059 

Impairment of intangible asset

 238,143    238,143  8,286 

Depreciation and amortization

  118,317   182,663   353,050   524,474   36,582   110,421   100,484   234,733 

Total operating expenses

 2,739,292  3,084,925  7,819,015  9,088,220   2,514,989   2,448,511   5,548,592   5,079,723 
                         

Loss from operations

 (2,654,877) (1,782,080) (6,215,566) (4,848,893)  (2,025,024)  (1,784,098)  (4,243,720)  (3,560,689)
                 

Other income/(expense)

                        

Interest income

       5 

Other Income

  891,103  891,103 
Loss of settlement of debt        (10,857)   

Interest expense

 (193,501) (88,331) (520,454) (144,714)  (244,443)  (167,126)  (482,889)  (326,953)

Loss on disposal of fixed assets

       (880)

Foreign currency gain (loss)

  (339)  (4,329)  2,470   (6,577)
Settlement Losses  (2,500)     (12,500)   
Foreign currency gain  (115)  (510)  (291)  2,809 

Total other income/(expense)

  (193,840)  798,443   (517,984)  738,937   (247,058)  (167,636)  (506,537)  (324,144)

Loss before income taxes

 (2,848,717) (983,637) (6,733,550) (4,109,956)  (2,272,082)  (1,951,734)  (4,750,257)  (3,884,833)

Income tax expense

                        

Net loss

  (2,848,717)  (983,637)  (6,733,550)  (4,109,956)  (2,272,082)  (1,951,734)  (4,750,257)  (3,884,833)

Other comprehensive loss, net of income tax

                        

Foreign currency translation adjustments

  (76,228)  (13,150)  (76,862)  (22,391)  (137)  12,261   31,365   (634)

Comprehensive loss

 $(2,924,945) $(996,787) $(6,810,412) $(4,132,347) $(2,272,219) $(1,939,473) $(4,718,892) $(3,885,467)

Net loss per share:

                        

Basic

 (0.05) (0.02) (0.12) (0.07)

Diluted

  (0.05)  (0.02)  (0.12)  (0.07)
Basic and Diluted  (0.03)  (0.03)  (0.07)  (0.07)

Weighted average number of shares:

                        

Basic

  60,297,083   55,410,695   58,544,432   55,410,695 
Basic and Diluted  65,670,815   58,602,319   63,884,441   57,921,596 

See accompanying notes to consolidated financial statements (unaudited).

2

2
Table of Contents

Mobivity Holdings Corp.

Condensed Consolidated Statement of Stockholders Equity (Deficit)Deficit

(Unaudited)

 

Common Stock

 

Equity

 

Additional Paid-in

 

Accumulated Other Comprehensive

 

Accumulated

 

Total Stockholders' Equity

  Shares  Dollars  Payable  Capital  Loss  Deficit  (Deficit) 
 

Shares

 

Dollars

 

Payable

 

Capital

 

Loss

 

Deficit

 

(Deficit)

  Common Stock  Equity  Additional Paid-in  Accumulated Other Comprehensive  Accumulated  Total
Stockholders’
 

Balance, December 31, 2020

 55,410,695  $55,411  $100,862  $101,186,889  $(23,446) $(99,575,503) $1,744,213 

Fair value of options issued with related party debt

    124,388 $ $ $124,388 
 Shares  Dollars  Payable  Capital  Loss  Deficit  Deficit 
Balance, December 31, 2022  61,311,155  $61,311  $324,799  $108,806,353  $(100,963) $(117,896,409) $    (8,804,909)
Issuance of common stock for warrant exercise  3,587,487   3,587      3,583,900         3,587,487 
Issuance of common stock for settlement of interest payable on related party debt  163,757   164   (7,713)  223,773         216,224 
RSU’s issued - termination of a director’s service  545,012   545      (545)         

Stock based compensation

       751,878      751,878            810,157         810,157 

Foreign currency translation adjustment

         (22,391)   (22,391)              31,502      31,502 

Net loss

                 (4,109,956)  (4,109,956)                 (2,478,175)  (2,478,175)

Balance, September 30, 2021

  55,410,695  $55,411  $100,862  $102,063,155  $(45,837) $(103,685,459) $(1,511,868)
Balance, March 31, 2023  65,607,411  $65,607  $317,086  $113,423,638  $(69,461) $(120,374,584) $(6,637,714)
Issuance of common stock for settlement of interest payable on related party debt  190,156   191  $(9,768)  216,033         206,456 
Stock based compensation           228,577         228,577 
Foreign currency translation adjustment              (137)     (137)
Net loss                $(2,272,082)  (2,272,082)
Balance, June 30, 2023  65,797,567  $65,798  $307,318  $113,868,248  $(69,598) $(122,646,666) $(8,474,900)

  Common Stock  Equity  Additional Paid-in  Accumulated Other Comprehensive  Accumulated  Total
Stockholders’
 
  Shares  Dollars  Payable  Capital  Loss  Deficit  Deficit 
Balance, December 31, 2021  55,410,695  $55,411  $100,862  $102,446,921  $(52,088) $(107,835,287) $    (5,284,181)
Issuance of common stock for warrant exercise  3,188,190   3,188      2,547,364         2,550,552 
Fair value of options issued with related party debt           6,201         6,201 
Stock based compensation           589,650         589,650 
Foreign currency translation adjustment              (12,895)     (12,895)
Net loss                 (1,933,099)  (1,933,099)
Balance, March 31, 2022  58,598,885  $58,599  $100,862  $105,590,136  $(64,983) $(109,768,386) $(4,083,772)
Beginning balance  58,598,885  $58,599  $100,862  $105,590,136  $(64,983) $(109,768,386) $(4,083,772)
Issuance of common stock for PIPE financing  1,062,500   1,062      848,937         849,999 
Fair value of options issued with related party debt           48,654         48,654 
Stock based compensation           211,775         211,775 
Foreign currency translation adjustment              12,261      12,261 
Net loss                 (1,951,734)  (1,951,734)
Balance, June 30, 2022  59,661,385  $59,661  $100,862  $106,699,502  $(52,722) $(111,720,120) $(4,912,817)
Ending balance  59,661,385  $59,661  $100,862  $106,699,502  $(52,722) $(111,720,120) $(4,912,817)

  

Common Stock

  

Equity

  

Additional Paid-in

  

Accumulated Other Comprehensive

  

Accumulated

  

Total Stockholders' Equity

 
  Shares  Dollars  Payable  Capital  Loss  Deficit  (Deficit) 

Balance, December 31, 2021

  55,410,695  $55,411  $100,862  $102,446,921  $(52,088) $(107,835,287) $(5,284,181)

Issuance of common stock for warrant exercise

  3,188,190   3,188      2,547,364         2,550,552 

Issuance of common stock for PIPE financing

  2,562,500   2,562      2,047,438         2,050,000 

Issuance of common stock for Settlement of Interest Payable on Related Party Debt

  149,770   150      164,021         164,171 

Fair value of options issued with related party debt

           73,469  ��      73,469 

Stock based compensation

           994,384         994,384 

Foreign currency translation adjustment

              (76,862)     (76,862)

Net loss

                 (6,733,550)  (6,733,550)

Balance, September 30, 2022

  61,311,155  $61,311  $100,862  $108,273,597  $(128,950) $(114,568,837) $(6,262,017)

See accompanying notes to consolidated financial statements (unaudited).

3

3
Table of Contents

Mobivity Holdings Corp.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 2023  2022 
 

Nine Months Ended

  Six Months Ended 
 

September 30,

  June 30, 
 

2022

 

2021

  2023  2022 

OPERATING ACTIVITIES

            

Net loss

 $(6,733,550) $(4,109,956) $(4,750,257) $(3,884,833)

Adjustments to reconcile net loss to net cash used in operating activities:

         

Loss on Settelment of Debt - related party

 2,421  
Loss on Settlement of Debt - related party  10,857    

Bad debt expense

 45,685  72,773   (545)  18,631 

Stock-based compensation

 994,384  751,878   1,038,734   801,425 

Loss on Disposal of Fixed Assets

   880 

Intangible asset impairment

 238,143  8,286 

Gain on Forgiveness of Debt

  (891,103)

Depreciation and amortization expense

 353,050  448,062   120,403   241,191 

Amortization of Debt Discount

 83,334  9,833   63,134   50,895 

Increase (decrease) in cash resulting from changes in:

         

Accounts receivable

 (337,347) (1,402,518)  539,017   (268,498)

Other current assets

 (17,148) 99,614   638   (123,940)

Operating lease assets/liabilities

 (15,029) 76,414   (19,918)  (6,461)

Contracts receivable, long-term

   707,928 

Other assets

   4,475   (276)   

Accounts payable

 (187,280) 1,368,027   69,073   (219,401)
Prepaid Expenses  (228,732)   

Accrued interest

 432,959  69,330   410,644   271,896 

Accrued and deferred personnel compensation

 (195,975) 258,916   (272,193)  (317,323)

Right to Use Lease

  (415,767)

Other liabilities - non-current

    

Other liabilities - current

 133,167  (135,273)  (34,379)  (9,071)

Deferred revenue and customer deposits

  236,827   (111,310)  (432,977)  (74,191)

Net cash used in operating activities

 $(4,966,359) $(3,189,511) $(3,486,777) $(3,519,680)
         

INVESTING ACTIVITIES

            

Purchases of equipment

 (18,712) (78,217)  (14,111)  (6,993)

Capitalized software development costs

  (12,030)  (310,546)

Net cash used in investing activities

  (30,742)  (388,763)  (14,111)  (6,993)
         

FINANCING ACTIVITIES

            

Payments on notes payable

 (29,145) (490,174)  (16,684)  (15,947)

Payments on related party notes payable

   (80,000)

Proceeds from related party debt

 800,000  1,456,250 
Proceeds from Related Party Debt     500,000 

Proceeds from conversion of common stock warrants

 2,550,552        849,999 

Proceeds from PIPE funding

  2,050,000    

Net cash provided by (used in) financing activities

  5,371,407   886,076 
Proceeds from conversion of common stock warrants  3,587,487   2,550,552 
Net cash provided by financing activities  3,570,803   3,884,604 
         

Effect of foreign currency translation on cash flow

 (92,985) (21,726)  32,816   (1,895)
         

Net Change in cash

 281,321  (2,713,924)  102,731   356,036 

Cash at beginning of period

 $735,424  $3,282,820  $426,740  $735,424 

Cash at end of period

 1,016,745 568,896   529,471   1,091,460 
 
 

Non cash investing and financing analysis:

    

Interest Paid

 $ $66,237 
Supplemental disclosures:        
Cash paid during period for:        
Interest $  $29,541 
Non-cash investing and financing activities:        
         

Fair Value of Options issued with related party debt

 $73,469  $  $  $54,855 

Refinancing of debt-related party

 $  $543,750 

Fixed Asset Contribution by Lessor

 $  $110,000 

Initial ROU and asset and lease liability

 $  $1,458,527 

Shares issued for settlement of debt - related party

 $161,750 $-  $411,823  $ 

Debt Discount on related party debt

 $  $124,388 
Shares issued for stock payable for settlement of debt - related party $223,937    
Par Value pf RSU’s issued - termiation of director’s service $545    

See accompanying notes to consolidated financial statements.

4
4

Table of Contents

Mobivity Holdings Corp.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1.Nature of Operations and Basis of Presentation

Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands, and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14,2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable, and intellectual property. We generate revenue by charging the resellers, brands, and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q10-Q and Rule 8-038-03 of Regulation S-XS-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K10-K for the year ended December 31, 20212022 filed with the SEC on March 30,2022.April 3, 2023.

In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of SeptemberJune 30, 2022,2023, and for the three and ninesix months ended SeptemberJune 30, 2022 2023 and 2021.2022. The results of operations for the three and ninesix months ended SeptemberJune 30, 20222023 are not necessarily indicative of the operating results for the full year ending December 31,2022. 2023.

2.Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.

Reclassifications

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications did not affect previously reported net losses.

Acquisitions

Acquisitions

We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.

Cash

Cash and Cash Equivalents

We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.

Accounts Receivable, Allowance for Doubtful Accounts and Concentrations

Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate.

As of SeptemberJune 30, 2022,2023, and December 31, 2021,2022, we recorded an allowance for doubtful accounts of $59,190$9,423 and $56,340$34,446 respectively.

Goodwill and Intangible Assets

Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.

5
5
Table of Contents

We conducted our annual impairment tests of goodwill as of December 31, 2021.2022. As a result of these tests, we had a total impairment charge of $85,169.$963,659.

Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year year to twenty years years. . No significant residual value is estimated for intangible assets.

The Company’s evaluation of its long-livedgoodwill and intangible assets resulted in $238,143 and $8,286 of intangibleno impairment expenses duringcharges for the ninesix months ended ended SeptemberJune 30, 20222023 and 2021,2022, respectively.

Software Development Costs

Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the Financial Accounting Standards Board ("FASB"(“FASB”) guidance for the costs of computer software to be sold, leased, or otherwise marketed (Accounting Standards Codification subtopic 985-20,985-20, Costs of Software to Be Sold, Leased, or Marketed, or “ASC Subtopic 985-20”985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. The technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense.

Capitalized costs for those products that are canceled or abandoned are charged to product development expenses in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-fourtwenty-four-month-month period.

The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development assets resulted in noimpairment charges of $0 for the quarterthree months ended SeptemberJune 30, 20222023 and $0 for the year ended December 31, 2021.2022, respectively

Impairment of Long-Lived Assets

We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.

Foreign Currency Translation

The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of ASC subtopic 830-10,830-10, Foreign Currency Matters (“ASC 830-10”830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income.

Revenue Recognition and Concentrations

Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and fees are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue.

Accounting Standards Update (“ASU”) No.2014-09, 2014-09, Revenue from Contracts with Customers (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1,2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues.

We determine revenue recognition under ASC 606 through the following steps:

identification of the contract, or contracts, with a customer;

identification of the performance obligations in the contract;

identification of the transaction price;

allocation of the transaction price to the performance obligations in the contract; and

recognition of revenue when, or as, we satisfy a performance obligation.

During the ninesix months ended SeptemberJune 30, 2023 and 2022, and 2021, two customers accounted for 50%51% and 54%49% of our revenues, respectively.

6
Table of Contents

6

Comprehensive Income (Loss)

Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at a comprehensive loss. For the ninethree months ended SeptemberJune 30, 2023 and 2022 and 2021, the comprehensive loss was $6,810,412,$2,272,219, and $4,132,347$1,939,473 respectively. For the six months ended June 30, 2023 and 2022, the comprehensive loss was $4,718,892 and $3,885,467 respectively.

Stock-based Compensation

We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.

Research and Development Expenditures

Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.

Advertising Expense

Direct advertising costs are expensed as incurred and consist primarily of trade shows, sales enablement, content creation, paid engagement and other direct costs. Advertising expense was $315,540$114,978 and $698,761$188,825 for the ninesix months ended SeptemberJune 30, 2023 and 2022, and 2021, respectively. The decrease in advertising expense is due to lower engagement and content creation costs.

Income Taxes

We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.

Net Loss Per Common Share

Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase, and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and ninesix months ended SeptemberJune 30, 2022 2023 and 2021,2022, we had securities outstanding which could potentially dilute basic earnings per share in the future. ThoseStock based compensation, stock options and warrants were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive.

Recent Accounting Pronouncements

Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following is a summary of recent accounting developments.

In August 2020, the FASB issued ASU 2020-06,2020-06, Accounting for Convertible Instruments and Contracts in an Entity'sEntity’s Own Equity (“ASU 2020-06”2020-06”). ASU 2020-062020-06 requires that the if-converted method of computing diluted Earnings per Share. The Company adopted ASU 2020-062020-06 on January 1,2022.

3.Going Concern

We had $1.0 millioin$529,471 of cash as of SeptemberJune 30, 2022. 2023. We had a net loss of $6.7 million$4,750,257 for the ninesix months then ended June 30, 2023, and we used $5.0 million$3,486,777 of cash in our operating activities during that time. In 2021,the six months ended June 30, 2022 we had a net loss of $4.1 million$3,884,833 and used $3.2 million$3,519,680 of cash in our operating expenses. We raised $2.6$3.6 million in cash from the exercise of warrants in February 2022 andof 2023. In addition, we have raised $2.1$1.1 million in Private Placement financingcash from the exercise in August 2023. There is substantial doubt that our additional cash from our warrant conversion along with our expected cash flow from operations, will be sufficient to date.fund our 12-month plan of operations, there can be no assurance that we will not require significant additional capital within 12 months.

As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $114.6$122.6 million as of SeptemberJune 30, 2022.2023. Further losses are anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next 12 months with proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

7
7

Table of Contents

4.Goodwill and Purchased Intangibles

Goodwill

Goodwill

The carrying value of goodwill at each of SeptemberJune 30, 20222023 and December 31, 20212022 was $411,183.$0.

The following table presents details of our purchased intangible assets as of SeptemberJune 30, 20222023 and December 31, 2021:2022:

Intangible assets

Schedule of Goodwill and Intangible Assets

 Balance at December 31, 2021 

Additions

 

Impairments

 

Amortization

 

Fx and Other

 Balance at September 30, 2022  Balance at December 31, 2022  Additions  Impairments  Amortization  Fx and Other  Balance at June 30, 2023 

Patents and trademarks

 $57,595  $  $  $(3,676) $3  $53,919  $52,698  $  $  $(2,445) $1  $50,254 

Customer and merchant relationships

 545,533    (238,143) $(72,635)   234,755   30,690        $(12,276)     18,414 

Trade names

 32,393      $(6,781)   25,612   8,050        $(3,221)     4,829 

Acquired technology

 112,191      $(12,224)   99,967 

Non-compete agreements

  29,212        $(11,895)     17,317 
 $776,924  $  $(238,143) $(107,211) $3  $431,570  $91,438  $  $  $(17,942) $1  $73,497 

The intangible assets are being amortized on a straight-line basis over their estimated useful lives of one year year to twenty years years..

Amortization expense for intangible assets was $35,724$17,942 and $35,738$71,478 for the threesix months ended SeptemberJune 30, 2023 and 2022, respectively, and 2021, respectively.is included in depreciation and amortization on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss.

Amortization expense for intangible assets was $107,211$8,972 and $107,478$32,590 for the ninethree months ended SeptemberJune 30, 2023 and 2022, and 2021, respectively.

The estimated future amortization expense of our intangible assets as of SeptemberJune 30, 20222023 is as follows:

Schedule of Finite Lived Intangible Assets Future Amortization Expense

Year ending December 31,

 

Amount

   Amount 

2022

 $35,736 

2023

 140,436   $17,942 

2024

 103,840    12,639 

2025

 59,042    4,891 

2026

 23,793    4,891 
2027   4,891 

Thereafter

  68,723    28,243 

Total

 $431,570   $73,497 

5.Software Development Costs

The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activitiesactivities.

The following table presents details of our software development costs as of SeptemberJune 30, 20222023 and December 31, 2021:2022:

Schedule of Software Development Costs

  Balance at December 31, 2021  

Additions

  

Amortization

  Balance at September 30, 2022 

Software Development Costs

 $347,796  $12,030  $(207,027) $152,799 
  $347,796  $12,030  $(207,027) $152,799 
  Balance at December 31, 2022  Additions  Amortization  Balance at June 30, 2023 
Software Development Costs $103,334  $  $(77,574) $25,760 
  $103,334  $  $(77,574) $25,760 

Software development costs are being amortized on a straight-line basis over their estimated useful life of two years.

8
8
Table of Contents

Amortization expense for software development costs was $61,764$35,629 and $104,870$71,974 for the three months ended SeptemberJune 30, 2023 and 2022, respectively, and 2021, respectively.is included in depreciation and amortization on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss.

Amortization expense for software development costs was $207,027$77,574 and $309,618$145,263 for the ninesix months ended SeptemberJune 30, 2023 and 2022, and 2021, respectively.

The estimated future amortization expense of software development costs as of SeptemberJune 30, 20222023 is as follows:

Schedule of Finite Lived Intangible Assets Future Amortization Expense

Year ending December 31,

 

Amount

   Amount 

2022

 $50,478 

2023

 98,300   $21,254 

2024

 4,021    4,506 

2025

      

2026

      
2027    

Thereafter

       

Total

 $152,799   $25,760 

6.Operating Lease Assets

The Company entered into a lease agreement on February 1,2021, for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $25,953$25,953 to $28,733.$28,733. The firsttwelve months of the lease included a 50% abatement period and a deposit of $110,000$110,000 was required. The lessor contributed $110,000$110,000 towards the purchase of office furniture as part of the lease agreement. As of SeptemberJune 30, 2022,2023, we have an operating lease asset balance of $1,032,132$878,380 and an operating lease liability balance of $1,247,395$1,065,155 recorded in accordance with ASC 842, Leases (ASC "842"“842”).

The following are additional details related to leases recorded on our balance sheet as of SeptemberJune 30, 2022:2023:

Schedule of Additional Details Related to Leases

Leases

Classification

 Balance at September 30, 2022  Classification Balance at
June 30, 2023
 

Assets

      

Current

     

Operating lease assets

Operating lease assets

 $  Operating lease assets $ 

Noncurrent

     

Operating lease assets

Noncurrent operating lease assets

 $1,032,132  Noncurrent operating lease assets $878,380 

Total lease assets

Total lease assets

 $1,032,132    $878,380 
     

Liabilities

      

Current

     

Operating lease liabilities

Operating lease liabilities

 $245,816  Operating lease liabilities $263,663 

Noncurrent

     

Operating lease liabilities

Noncurrent operating lease liabilities

 $1,001,579  Noncurrent operating lease liabilities $801,492 

Total lease liabilities

Total lease liabilities

 $1,247,395    $1,065,155 

9
9
Table of Contents

The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term, and weighted average discount rate:

Year ending December 31,

    

2022

 $79,526 

2023

  324,221 

2024

  330,894 

2025

  337,568 

2026

  344,241 

Thereafter

  28,733 

Total future lease payments

  1,445,183 

Less: imputed interest

  (197,788)

Total

 $1,247,395 

Schedule of Lessee, Operating Lease Liability

Year ending December 31,    
2023  $162,389 
2024   330,894 
2025   337,568 
2026   344,241 
2027   28,733 
Thereafter    
Total future lease payments   1,203,825 
Less: imputed interest   (138,670)
Total  $1,065,155 

Schedule of Lease Cost

Weighted Average Remaining Lease Term (years)

   

Operating leases

  5.93.58 
     

Weighted Average Discount Rate

    

Operating leases

  6.75%

7.Notes Payable and Interest Expense

The following table presents details of our notes payable as of SeptemberJune 30, 20222023 and December 31, 2021:2022:

Facility

 

Maturity

 

Interest Rate

  Balance at September 30, 2022  Balance at December 31, 2021 

ACOA Note

 

February 1, 2024

     43,510   76,642 

TD Bank

 

December 31, 2022

     29,031   31,496 

Related Party Note

 

various

  15%  4,128,107   3,318,242 

Total Debt

      4,200,648   3,426,380 

Less current portion

      (1,848,375)  (888,583)

Long-term debt, net of current portion

     $2,352,273  $2,537,797 

Schedule of Debt

Facility Maturity  Interest Rate  Balance at June 30, 2023  Balance at December 31, 2022 
ACOA Note  February 1, 2024      18,096   34,231 
TD Bank  December 31, 2023      30,223   29,478 
Related Party Note  various   15%  4,983,720   5,192,461 
Total Debt          5,032,039   5,256,170 
Less current portion          (1,379,346)  (2,743,788)
Long-term debt, net of current portion         $3,652,693  $2,512,382 

ACOA Note

On November 6,2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2,2014, with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement, the note will mature, and the commitments will terminate on February 1,2024. The monthly principal payment amount of $3,000$3,000 CAD increased to $3,500$3,500 CAD beginning on November 1,2019, $4,000 $4,000 CAD on August 1,2021, $4,500 $4,500 CAD on August 1,2022, and $2,215$2,215 CAD during the remaining term of the agreement. Payments from April- December April-December of 2020 were voluntarily deferred by ACOA due to COVID-19.COVID-19.

During the ninesix months ended SeptemberJune 30, 20222023 we repaid $32,263$16,684 USD of principal.

Chase Loan

On April 10,2020, we entered into a commitment loan with Chase Bank, N.A. under the CARES act and SBA Paycheck Protection Program, in the principal aggregate amount of $891,103, which is due and payable two years after issuance. This note bears interest on the unpaid balance at the rate of one percent (1%) per annum. The note contains a deferral period of six months, for which no interest or principal payments are due. Forgiveness of the loan may be obtained by meeting certain SBA requirements. The entire loan was forgiven on July 21, 2021, at which time the company recorded a gain on extinguishment of debt in the amount of $891,103.

TD Bank Loan

On April 22,2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $40,000 $40,000 CAD, which is due and payable on December 31,2023. This note bears interest on the unpaid balance at the rate of zero percent (0%(0%) per annum during the initial term. Under this note, no interest or principal payments are due until December 31,2023. Under the conditions of the loan, thirty-three percent (33%(33%) of the loan will be forgiven if sixty-seven percent (67%(67%) is repaid prior to the initial term date.

Related Party Notes

Secured Promissory Notes

On June 30,2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with Thomas Akin, one of the Company’s directors (the "Lender"“Lender”). The Credit Agreement was amended on November 11, 2022. The Company can borrow up to $6,000,000$6,000,000 under thisthe Credit Agreement amended on September 30, 2022. As of December 31, 2021, (“the company has drawn a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the“Credit Facility”).

The Credit Facility and paid a total of $200,000 toward the principal balance of the loan,

The loan is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen percent (15%(15%) per annum. The Company may prepay this loan without notice, penalty, or charge. In consideration of the lender’sLender’s agreement to provide the facility,Credit Facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67$1.67 per share in connection with the issuance of funds under thisthe Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the corresponding notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lenderLender additional warrants entitling the lenderLender to purchase a number of shares of the Company'sCompany’s common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the "VWAP"“VWAP”). Each warrant will be exercisable over a three-yearthree-year period at an exercise price equal to the VWAP.

10
Table of Contents

Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. On August 13,November 11, 2022, the Lender agreed to postpone the 24-month repayment period to a later period commencing on January 31,2022, and further agreed that interest accrued on the loan between July 1, 2022 and December 31, 2022 is to be settled in shares of the Company’s common stock.

On June 10, 2022, The Company took a draw of an additional $500,000 under the Credit Agreement. 

On August 09, 2022 the Company took a draw of an additional $300,000 under the credit agreement.

During the nine months period ending September 30, 2022, the Company issued warrants to purchase an aggregate of 177,571 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under the Credit Agreement. The estimated aggregate fair value of the warrants issued is $73,469 using the Black-Scholes option valuation model as of September 30, 2022.

As of September 30, 2022, the Company has drawn a total of $4,078,125 including cash in the amount of $3,806,250, and $271,875 of principal and accrued interest under the above-described UP Notes which were rolled into the Credit Agreement, and we have accrued interest of $387,918. A total of $151,398 of accrued interest was settled into 140,185 shares of common stock and the Company recorded a loss on debt settlement of interest payable $2,259.

On November 13, 2022, an amendment to the Credit Facility agreementAgreement was signed. The amendment updated the payment terms to the following: "Without“Without limiting the foregoing Section 2.3(a)2.3(a), Borrower shall repay the principal amount of all Advances, plus accrued interest thereon, in 24 equal monthly installments commencing on January 31, 2023 and continuing thereafter on the last day of each month (or, if such last day is not a Business Day, on the Business Day immediately preceding such last day. Interest on the unpaid Advances will accrue from the date of each Advance at a rate equal to fifteen percent (15%(15%) per annum. Interest will be calculated on the basis of 365 days in a year." The amendment raised the maximum amount of the Credit AgreementFacility to $6,000,000.$6,000,000. In addition, the interest which is accrued monthly between July 1, 2022, and December 31, 2022, will be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08$1.08 per share of Common Stockcommon stock in the amount of the interest accrued for each month.

On January 31, 2023, the Company then entered into Amendment No. 1 (the “Amendment”), which amends our existing Credit Facility Agreement, dated as of November 11, 2022, between the Company and Thomas B. Akin, and any convertible notes issued thereunder. The Amendment amends the existing Credit Facility Agreement to extend the maturity of the agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the agreement is to be paid quarterly in shares of our common stock, at a price per share equal to the volume-weighted average price of our common stock quoted on the Over-The Counter Venture Market operated by OTC Markets Group Inc. (“OTCQB®”) over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible notes to be issued under the Credit Agreement in the future and any outstanding convertible notes issued under the existing Credit Facility Agreement. The Amendment was considered a debt modification as the cash flows under the amended terms do not differ by at least 10% from the cash flows under the original agreement.

During the six months ended June 30, 2023, a total of $391,319 of interest was accrued by the company. The interest payable to Thomas Akin was then surrendered to be converted and exchanged for the issuance of 362,335 shares of restricted common stock. The company recorded a loss of settlement of interest payable of $10,315 and amortized discount expense of $59,983.

As of June 30, 2023, the Company had drawn a total of $5,173,125 and we have accrued interest of $439,968 and a discount balance of $179,948.

Unsecured Promissory Note

On July 1,2021, we entered into Unsecured PromissoryUP Notes (each individually, a “UP Note” and collectively, the “UP Notes”) in the aggregate principal amount of $271,875 to certain investors, officers,$271,875 with Talkot Fund, LP and directors ofinvestor in the Company. Each UP Note bears interest on the unpaid balance at the rate of fifteen percent (15%(15%) per annum and the principal and accrued interest are due and payable no later than December 31, 2023. We may prepay any of the UP Notes without notice, subject to a two percent (2%(2%) pre-payment penalty. The UP Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued to Talkot Fund LP warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement.UP Note.

On August 13, 2022, an amendmentJanuary 31, 2023, the Lender agreed to postpone the Credit Facility agreement was24-month repayment period to a later period commencing on January 31, 2024, and further agreed upon. The amendment updated the date to begin payment from July 31, 2022, to December 31, 2022. In addition, thethat interest accrued monthlyon the loan between July 1, 2022 and December 31, 2022, will1, 2025 is to be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08 per share of Common Stock in the amountshares of the Company’s common stock quarterly.

During the six months ended June 30, 2023, a total of $20,504 of interest was accrued by the company. The interest payable to Talkot Fund, LP was then surrendered to be converted and exchanged for each month.the issuance of 18,987 shares of restricted common stock. The company recorded a loss of settlement of interest payable of $542 and amortized discount costs of $3152.

As of SeptemberJune 30, 2022, The2023, the Company has ahad an outstanding principal balance of $271,875,$271,875, accrued interest of $55,530$20,504 and a discount balance of $9,457.

Interest Expense

Interest expense was $244,443 and $167,126 during the three months ended June 30, 2023 and 2022, respectively.

Interest expense was $482,889 and $326,953 during the six months ended June 30, 2023 and 2022, respectively.

11
Table of Contents

8. Stockholders’ Equity

Common Stock and Equity Payable

2022

On February 9, 2022, 17 warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $0.80 per share, resulting in additional capital of $2,550,552. As an inducement for the holders’ exercise of the warrants, we issued the holders 3,188,190 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in February 2025. We have recorded an additional stock-based expense of $382,048 in 1st quarter of 2022.

On June 29, 2022, the Company received private investment funds to purchase 1,062,500 shares of its common stock at a price of $0.80 per share, resulting in additional capital of $850,000, and issued the holders 1,062,500 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in June 2025.

On August 24, 2022, the Company received private investment funds to purchase 1,500,000 shares of its common stock at a price of $0.80 per share, resulting in additional capital of $1,200,000, and issued the holders 1,500,000 new warrants to purchase common stock at $1.50 per share over a three year period expiring in August 2025.

On November 13, 2022 a total of $10,352 of interest was converted into 9,585140,185 shares of common stock andwere issued from equity payable to Thomas Akin as settlement of $151,398 of interest payable. The Company recorded a loss on settlement of interest payable of $162.

Interest Expense

Interest expense was $193,501 and $88,331 during the three months ended September 30, 2022 and 2021, respectively.

Interest expense was $520,454 and $144,714 during the nine months ended September 30, 2022 and 2021, respectively.  

8. Stockholders Equity

Common Stock

$2,259.

2021

During the year ended December 31, 2021, the Company did not issue anyOn November 13, 2022 a total of 9,585 shares but, recorded a stock-based compensation expense of $260,005 relatedcommon stock were issued from equity payable to restricted stock units for membersTalkot Fund LP as settlement of our board$10,352 of directors.interest payable. The Company recorded a stock-basedloss on settlement of interest payable of $162.

On December 31, 2022 a total of $166,432 of interest was accrued and settled to equity payable for the issuance of 154,106 shares of common stock. The company recorded a loss of settlement of interest payable of $44,325.

On December 31, 2022 a total of $10,423 of interest was accrued and settled to equity payable for the issuance of 9,651 shares of common stock. The company recorded a loss of settlement of interest payable of $2,757,

2023

On January 31, 2023 a total of 545,012 shares were issued to John Harris, a former director. The shares were issued based on the total Restricted Stock Units earned by Mr. Harris as director compensation that were fully vested as of March 29, 2022. Restricted stock expense of $187,501 related to restricted stock units for employee compensation.

10

is recorded on the date it vests and 2022no expense was recognized during the six months ended June 30, 2023.

On February 9,2022, 17March 27, 2023 a total of 154,106 shares of common stock were granted from equity payable to Thomas Akin as settlement of $166,432 of interest payable. The Company recorded a loss on settlement of interest payable of $44,325 on December 31, 2022.

On March 27, 2023 a total of 9,651 shares of common stock were granted from equity payable to Talkot Fund LP as settlement of $10,423 of interest payable. The Company recorded a loss on settlement of interest payable of $2,757 on December 31, 2022.

On March 31, 2023 a total of $195,171 of interest for 1stquarter and was accrued and settled to equity payable for the issuance of 180,715 shares of common stock that was issued on May 8, 2023. The company recorded a loss of settlement of interest payable of $10,315.

On March 31, 2023 a total of $10,196 of interest for 1st quarter and was accrued and settled to equity payable for the issuance of 9,441 shares of common stock that was issued on May 8, 2023. The company recorded a loss of settlement of interest payable of $542.

During March, 15 warrant holders exercised their common stock purchase warrant for 3,188,190 3,587,487 shares at the exercise price of $0.80$1.00 per share, resulting in additional capital of $2,550,552.$3,557,487. As an inducement for the holders'holder’s exercise of the warrants, we issued the holders 3,188,190holders’ 1,793,745 new warrants to purchase common stock at $1.50$2.00 per share over a three-yearthree-year period expiring in February 2025. We haveThe Company recorded an additional$577,000 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of $382,048.the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

On June 29, 2022, the Company received private investment funds to purchase 1,062,500 shares of its common stock at a price of  $0.80 per share, resulting in additional capital of $850,000, and issued the holders 1,062,500 new warrants to purchase common stock at $1.50 per share over a three-year period expiring in June 2025.

On August 24,2022, the Company received private investment funds to purchase 1,500,000 shares of its common stock at a price of  $0.80 per share, resulting in additional capital of $1,200,000, and issued the holders 1,500,000 new warrants to purchase common stock at $1.50 per share over a three year period expiring in August  2025.

During the nine months ended September 30, 20222023 a total of $161,750$196,148 of interest was converted into 149,770 accrued and settled to equity payable for the issuance of 181,620 shares of Common Stock.common stock.

12
Table of Contents

On June 30, 2023 a total of $10,309 of interest was accrued and settled to equity payable for the issuance of 9,546 shares of common stock.

During the ninesix months ended SeptemberJune 30, 2022 The Company recorded2023 a stock-based compensation expensetotal of $ 195,005163,757 shares were issued from stock payable related to restricted stock units for members of our board of directors. The company recorded a stock-based compensation expense of $799,379 related to stock units for employee compensation.party accrued interest.

As of the nine months ended SeptemberJune 30, 20222023 we had an equity payable balance of $100,862.$307,318.

Stock-based Plans

Stock Option Activity

The following table summarizes stock option activity for the ninesix months ended SeptemberJune 30, 2022.2023.

Share Based Payment Arrangement Options Activity

  

Options

 

Outstanding at December 31, 2020

6,007,552

Granted

637,500

Exercised

Forfeited/canceled

(272,029)

Expired

(126,557)

Outstanding at December 31, 2021

  6,246,466 

Granted

  1,195,0001,375,000 

Exercised

   

Forfeited/canceled

  (330,623)

Expired

  (484,209599,627)

Outstanding at September 30,December 31, 2022

  6,626,6346,691,216 
Granted295,000
Exercised
Forfeited/canceled(72,916)
Expired(1,330,592)
Outstanding at June 30, 20235,582,708

The weighted average exercise price of stock options granted during the period was $0.96 and the related weighted average grant date fair value was $0.61 per share.

20212022

On March 26,2021,29, 2022, the Company granted five employees a total of 67,500one employee 150,000 options to purchase shares of the Company'sCompany’s common stock at the closing price as of March 26,2021,29, 2022, of $1.80$0.8289 per share. The option shares will vest 25%25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until March 26,2031.29, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.97%72.33% and an option fair value of $1.16$0.54 was $78,492.$81,035.

On May 2,2021,16, 2022, the Company granted one employee a total of 20,000three employees 45,000 options to purchase shares of the Company'sCompany’s common stock at the closing price as of May 2,2021,16, 2022, of $1.48$0.97 per share. The option shares will vest 25%25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until May 2,2031.16, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.79%73.45% and an option fair value of $0.93$0.642608 was $18,628.$28,917.

On August 11,2021,September 22, 2022, the Company granted one employee a total of 5,0001,000,000 options to purchase shares of the Company'sCompany’s common stock at the closing price as of August 11,2021,September 2022, of $1.75$0.98 per share. The option shares will vest 25%25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until August 11,2031.September 29, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.29%76.15% and an option fair value of $1.12$0.697499 was $5,606.

$697,499.

2022

2023

On March 29,2022,

During the six months ended June 30, 2023 the Company granted one employee 150,000three employees 295,000 options to purchase shares of the Company'sCompany’s common stock at the closing price as of March 29,2022,May 11, 2023 of $0.8289$0.98 per share. The option shares will vest 25%25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until March 29,2032.May 16, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 72.33%75.76% and an option fair value of $0.54$0.705183 was $81,035.$208,029.

13
Table of Contents

On May 16, 2022, the Company granted three employees 45,000 options to purchase shares of the Company's common stock at the closing price as of May 16, 2022, of $0.97 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until May 16, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.45% and an option fair value of $0.642608 was $28,917.

On September 22, 2022, the Company granted one employee 1,000,000 options to purchase shares of the Company's common stock at the closing price as of September 2022, of $0.98 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until September 29, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 76.15% and an option fair value of $0.697499 was $697,499.

11

Stock-Based Compensation Expense from Stock Options and Warrants

The impact on our results of operations of recording stock-based compensation expense for the three and ninesix months ended SeptemberJune 30, 2022 2023 and 20212022 were as follows:

  

Three Months Ended

  

Nine Months Ended

 
  

September 30,

  

September 30,

 
  

2022

  

2021

  

2022

  

2021

 

General and administrative

 $65,800  $62,684  $571,462  $226,572 

Sales and marketing

  20,972   19,522   56,183   83,335 

Engineering, research, and development

  41,185   43,861   171,734   130,519 
  $127,957  $126,067  $799,379  $440,426 

Schedule of Stock-based Compensation Expense

  2023  2022  2023  2022 
  Three Months Ended  Six Months Ended 
  June 30,  June 30, 
  2023  2022  2023  2022 
General and administrative $53,750  $377,415  $118,783  $505,661 
Sales and marketing  71,796   22,344   140,442   35,211 
Engineering, research, and development  38,029   64,059   72,504   130,549 
Total $163,575  $463,818  $331,729  $671,421 

Valuation Assumptions

The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the ninesix months ended SeptemberJune 30, 2022 2023 and 2021.2022.

  

Nine Months Ended

 
  

September 30,

 
  

2022

  

2021

 

Risk-free interest rate

  2.47%  1.00%

Expected life (years)

  5.90   6.00 

Expected dividend yield

  %  %

Expected volatility

  69.23%  73.99%

Schedule of Stock Options Valuation Assumptions

  Six Months Ended 
  June 30, 
  2023  2022 
Risk-free interest rate  3.37%  2.55%
Expected life (years)  7.00   6.00 
Expected dividend yield  %  %
Expected volatility  75.76%  72.59%

The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options.

The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on the historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of the Company'sCompany’s stock-based awards.

The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts.

The expected volatility in 20222023 and 20212022 is based on the historical publicly traded price of our common stock.

Restricted stock units

The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 20212022 and for the ninesix months ended SeptemberJune 30, 2022:2023:

Schedule of Restricted Stock Unit Activity

  

Shares

 

Outstanding at December 31, 2020

2021
  1,436,7281,685,141 

Awarded

  654,663244,792 

Released

   

Canceled/forfeited/expired

Outstanding at December 31, 20221,929,933
Awarded141,484
Released  (406,250545,012)

Outstanding at December 31, 2021

Canceled/forfeited/expired
  1,685,141 

Awarded

Outstanding at June 30, 2023
  197,688

Released

Canceled/forfeited/expired

Outstanding at September 30, 2022

1,882,8291,526,405 
     

Expected to vest at SeptemberJune 30, 2022

2023
  1,882,8291,526,405 

Vested at SeptemberJune 30, 2022

2023
  1,882,8291,526,405 

Unvested at SeptemberJune 30, 2022

2023
   

Unrecognized expense at SeptemberJune 30, 2022

2023
 $ 

14
Table of Contents

20212022

On March 26,2021,29, 2022, the Company issued to company granted four independent directors a total of 36,11278,420 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the first quarter of 2021. The units were valued at $65,002$65,002 or $1.80$0.829 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) March 26,December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On March 26,2021,May 16, 2022, the Companycompany granted to one employee 1,000,000 restricted shares of the Company’s common stock at $1.80 per share, closing price as of March 26,2021, all of which were subsequently forfeited upon the termination of the employee’s service with the Company on December 31, 2022.

12

On May 12,2021, the Company issued to four independent directors a total of 38,92454,168 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the second quarter of 2021. The units were valued at $65,002$65,002 or $1.67 $1.20 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) May 2,December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On August 11,2021,September 30, 2022, the Company issued tocompany granted four independent directors a total of 37,14365,100 restricted stock units. These restricted stock units were issued for the $65,000 of board compensation earned for the third quarter of 2021. The units were valued at $65,000$65,002 or $1.75$ per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) August 11,December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On December 15,2021,31, 2022 the Company granted four independent directors a total of 42,48447,104 restricted stock units. The units were valued at $65,000$65,004 or $1.53$1.38 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15,2024,31, 2025, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

During the yearsix months ended December 31. 2021 June 30, 2022, the companyCompany recorded $260,003$65,002 in restricted stock expense as board compensation and $187,501 in restricted stock expense as employee compensation.

2022

2023

On March 29, 2022, 31, 2023, the company grated granted four independent directors a total of 78,42061,342 restricted stock units. The units were valued at $65,002$65,002 or $0.829$1.05 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15,2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On May 16,2022,June 30, 2023, the company grated granted four independent directors a total of 54,16880,160 restricted stock units. The units were valued at $65,002$65,003 or $1.20$0.81 per share, based on the closing stock price on the date of the grant. All units vestedvest immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15,2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

On September 30, 2022, the company grated granted four independent directors a total of 65,100 restricted stock units. The units were valued at $65,002 or $.9985 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) December 15,2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

In the ninesix months ended SeptemberJune 30, 2022,2023, the Company recorded $ 195,005130,005 in restricted stock expense as board compensation.

Stock Based Compensation from Restricted Stock

The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and ninesix months ended SeptemberJune 30, 2022 2023 and 20212022 was as follows:

  

Three Months Ended

  

Nine Months Ended

 
  

September 30,

  

September 30,

 
  

2022

  

2021

  

2022

  

2021

 

General and administrative

 $65,002  $65,000  $195,005  $195,005 

Sales and marketing

 $  $56,635  $  $116,347 
  $65,002  $121,635  $195,005  $311,352 

Schedule of Stock-based Compensation Expense

  2023  2022  2023  2022 
  Three Months Ended  Six Months Ended 
  June 30,  June 30, 
  2023  2022  2023  2022 
General and administrative $65,002  $65,002  $130,005  $130,004 
Sales and marketing $  $  $  $ 
Total $65,002  $65,002  $130,005  $130,004 

As of SeptemberJune 30, 2022,2023, there was no unearned restricted stock unit compensation.

Warrants

The following table summarizes investor warrants as of SeptemberJune 30, 20222023 and the years ended December 31, 2021 2022 and 2020:

  

Shares

  

Weighted Average Exercise Price

  

Weighted Average Remaining Contractual Term (Years)

 

Outstanding at December 31, 2020

  2,691,459  $1.99   2.94 

Granted

  580,231  $    

Exercised

    $    

Canceled/forfeited/expired

  (25,000) $    

Outstanding at December 31, 2021

  3,246,690  $2.26   3.59 

Granted

  5,928,261  $    

Exercised

  (3,188,190) $    

Canceled/forfeited/expired

    $    

Outstanding at September 30, 2022

  5,986,761  $2.72   2.02 

13

20212021:

On June 30,2021, the Company issued warrants to purchase an aggregate of 227,994 shares of its common stock at an exercise price of $1.67 per share for 119,760 inducement warrants and VWAP for 108,234 additional warrants in connection with the issuance of a loan by a related party. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. The estimated aggregate fair value of the warrants issued is $119,103 using the Black-Scholes option valuation model.

On August 11,2021, the Company issued warrants in connection with the Credit Facility Agreement by the related party exercisable at a rate equal to the 30-day VWAP for 10,072 additional warrants in connection with the issuance of a loan by a related party. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. The estimated aggregate fair value of the warrants issued is $5,285 using the Black-Scholes option valuation model

As of September 30,2021, we had outstanding warrants to purchase 2,666,459 shares of common stock at $2.06 per share. These warrants expire in 2023. We also have outstanding warrants to purchase 238,066 shares of common stock at the stated price per share in connection with the issuance of a loan with a related party. These warrants expire in 2024.

2022Schedule of Investor Warrants

  Shares  Weighted Average Exercise Price  Weighted Average Remaining Contractual Term (Years) 
Outstanding at December 31, 2021  3,246,690  $2.26   3.59 
Granted  6,089,398  $    
Exercised    $    
Canceled/forfeited/expired  (3,188,190) $    
Outstanding at December 31, 2022  6,147,898  $1.45   2.27 
Granted  1,793,745  $    
Exercised  (3,587,487) $    
Canceled/forfeited/expired    $    
Outstanding at June 30, 2023  4,354,156  $1.69   2.14 

15
Table of Contents

2022

On February 9,2022,17 warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $0.80$0.80 per share, resulting in additional capital of $2,550,553.$2,550,553. As an inducement for the holder’s exercise of the warrants, we issued the holders' holders’ 3,188,190 new warrants to purchase common stock at $1.50 $1.50 per share over a three-year period expiring in February 2025. The Company recorded $382,048$382,048 of stock-based expense related to warrants issued during the warrant conversion offer on February 9, 2022.

On June 29, 2022, six private investors purchased 1,062,500 new warrants to purchase common stock at $1.50$1.50 per share over a three-yearthree-year period expiring in June 2025, and 1,062,500 shares at the exercise price of $0.80$0.80 per share, resulting in additional capital of $850,000. $850,000.

On August 24, 2022, five private investors purchased 1,500,000 new warrants to purchase common stock at $1.50$1.50 per share over a three-yearthree-year period expiring in August 2025, and 1,500,000 shares at the exercise price of $0.80$0.80 per share, resulting in additional capital of $1,200,000. $1,200,000.

2023

During the ninesix months ended SeptemberJune 30, 2022,2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the Companyexercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders 1,793,745 new warrants to purchase an aggregate of 177,571 shares of its common stock at the stated exercise price$2.00 per share over a three-year period expiring in connection withFebruary 2025. The Company recorded $577,000 of stock-based expense related to warrants issued during the issuance of funds under the Credit Agreement.warrant conversion offer on February 14, 2023. The total estimated aggregate fair value of the warrants issued is $73,469 using the Black-Scholes Model is based on a volatility rate of 63% and an option valuation model asfair value of September 30, 2022$0.3216.

9.Fair Value Measurements

Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-tierthree-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1)1) observable inputs such as quoted prices in active markets; (Level 2)2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3)3) unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure certain financial assets and liabilities at fair value.

The following table presents assets that are measured and recognized at fair value as of SeptemberJune 30, 20222023 on a recurring and non-recurring basis:

Schedule of Fair Value Measurements Recurring and Nonrecurring

Description

 

Level 1

 

Level 2

 

Level 3

 

Gains (Losses)

  Level 1  Level 2  Level 3  Gains
(Losses)
 

Goodwill (non-recurring)

 $  $  $411,183  $  $  $  $  $ 

Intangibles, net (non-recurring)

 $  $  $584,369  $  $  $  $99,257  $ 

The following table presents assets that are measured and recognized at fair value as of December 31, 20212022 on a recurring and non-recurring basis:

Description

 

Level 1

 

Level 2

 

Level 3

 

Gains (Losses)

  Level 1  Level 2  Level 3  Gains
(Losses)
 

Goodwill (non-recurring)

 $  $  $411,183  $  $  $  $  $ 

Intangibles, net (non-recurring)

 $  $  $1,124,720  $  $  $  $194,772  $ 

10.Commitments and Contingencies

Litigation

AsThe company had a pending legal proceeding related to a Telephone Consumer Protection Act (“TCPA”) violation. This is a putative class action complaint alleging that the defendant initiated telephone solicitations through text messages in violation of the dateFlorida Telephone Solicitation Act, Fla. Stat. §501.059 (“FTSA”). The defense of the matter was tendered to the Company by its client, Sonic Industries, Inc. During the six months ended June 30, 2023, the Company has settled four TCPA claims for a total settlement loss of $12,500 and this report, there are no pending legal proceedings to which we or our properties are subject.amount is included within settlement losses on the accompanying unaudited consolidated statements of operations and comprehensive loss.

Operating Lease

As described in Note 6, the Company has a lease agreement for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $25,953$25,953 to $28,733.$28,733. The first12 months of the lease included a 50% abatement period. As of SeptemberJune 30, 2022,2023, we have an operating lease asset balance for this lease of $1,032,132and$878,380 and an operating lease liability balance for this lease of $1,247,395recorded$1,065,155 recorded in accordance with ASC 842.

16
14

Table of Contents

11.Related Party Transactions

Secured Promissory Notes

On June 30, 2021, we entered into a Credit Facility Agreement with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Facility Agreement was amended on November 11, 2022 to allow the Company to borrow up to $6,000,000. The Credit Facility Agreement was amended again on January 31, 2023 to extend the maturity of the agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025.

Unsecured Promissory Note Investments

2021

On July 1,2021, we entered into an Unsecured PromissoryUP Notes (each, individually, a “UP Note” and collectively, the “UP Notes”) in the aggregate principal amount of $271,875 to certain investors, officers,$271,875 with Talkot Fund, LP and directors ofinvestor in the Company. Each UP Note bears interest on the unpaid balance at the rate of fifteen percent (15%(15%) per annum and the principal and accrued interest are due and payable no later than December 31, 2023.We may prepay any

For more details regarding the two related party transactions, please refer to Note 7 - Notes Payable and Interest Expense.

Related Party Warrant Exercise

On March 2, 2023, Thomas Akin exercised his common stock purchase warrant for 749,987 shares at the exercise price of $1.00 per share, resulting in additional capital of $749,987. As an inducement for the holder’s exercise of the UP Notes without notice, subject to a two percent (2%) pre-payment penalty. The UP Note offer was conducted by our management and there were no commissions paid by us in connection withwarrants, we issued the solicitation. The Company issuedholder 374,994 new warrants to purchase an aggregate of 33,017 shares of its common stock at $2.00 per share over a three-year period expiring in March 2026. The Company recorded $120,598 of stock-based expense related to warrants issued during the statedwarrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

On February 7, 2022, Talkot Fund LP exercised their common stock purchase warrant for 750,000 shares at the exercise price of $1.00per share, resulting in connection withadditional capital of $750,000. As an inducement for the issuanceholder’s exercise of funds under the Credit Agreement.

warrants, we issued the holder 2022375,000

On August 13, 2022, an amendment new warrants to the Credit Facility agreement was agreed upon. The amendment updated the date to begin payment from July 31, 2022, to December 31, 2022. In addition, the interest accrued monthly between July 1, 2022, and December 31, 2022, will be settled into equity. Common Stock will be issuedpurchase common stock at the end of each month at a rate of $1.08$2.00 per share over a three-year period expiring in March 2026. The Company recorded $120,600of Common Stock instock-based expense related to warrants issued during the amountwarrant conversion offer on February 14, 2023. The total estimated value of the interest accrued for each month.warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

As of September 30, 2022, The Company has a principal balance of $271,875, accrued interest of $55,530 and12. Subsequent Events

On July 17, 2023, a total of $10,352 of interest was converted into 9,585181,620 shares of common stock and The Company recorded a gain onwere issued to Thomas Akin as settlement of interest payable of $162.

Secured Promissory Note Investments

payable.

2021

On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $6,000,000 under this Credit Agreement amended on September 30, 2022. As of December 31, 2021, the company has drawnJuly 17, 2023, a total of $3,478,125 including cash9,546 shares were issued to Talkot Fund, LP as settlement of interest payable.

2023 Warrants Exercise

During the quarter ended August 07, 2023, 5 warrant holders exercised their common stock purchase warrant for 1,303,660 shares at the exercise price of $0.82 per share, resulting in additional capital of $1,069,000.38. As an inducement for the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility and paid a total of $200,000 toward the principal balanceholder’s exercise of the loan,

The loan is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest onwarrants, we issued the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this loan without notice, penalty, or charge. In consideration of the lender’s agreement to provide the facility, the Company issuedholders 2,607,318 new warrants to purchase shares of its common stock at an exercise price of $1.67$0.82 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company's common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the "VWAP"). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP.  Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest,expiring in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. On August 13, 2022, the Lender agreed to postpone the 24-month repayment period to a later period commencing on January 31, 2022, and further agreed that interest accrued on the loan between July 1, 2022 and December 31, 2022 is to be settled in shares of the Company’s common stock.

2026.

2022

17
Table of Contents

On June 10, 2022, The Company took a draw of an additional $500,000 under the Credit Agreement. 

On August 09, 2022 the Company took a draw of an additional $300,000 under the credit agreement.

During the nine months period ending September 30, 2022, the Company issued warrants to purchase an aggregate of 177,571 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under the Credit Agreement. The estimated aggregate fair value of the warrants issued is $73,469 using the Black-Scholes option valuation model as of September 30, 2022.

As of September 30, 2022, the Company has drawn a total of $4,078,125 including cash in the amount of $3,806,250, and $271,875 of principal and accrued interest under the above-described UP Notes which were rolled into the Credit Agreement, and we have accrued interest of $387,918. A total of $151,398 of accrued interest was settled into 140,185 shares of common stock and the Company recorded a loss on debt settlement of interest payable $2,259.

On November 13, 2022, an amendment to the Credit Facility agreement was signed. The amendment updated the payment terms to the following: "Without limiting the foregoing Section 2.3(a), Borrower shall repay the principal amount of all Advances, plus accrued interest thereon, in 24 equal monthly installments commencing on January 31, 2023 and continuing thereafter on the last day of each month (or, if such last day is not a Business Day, on the Business Day immediately preceding such last day. Interest on the unpaid Advances will accrue from the date of each Advance at a rate equal to fifteen percent (15%) per annum. Interest will be calculated on the basis of 365 days in a year." The amendment raised the maximum amount of the Credit Agreement to $6,000,000. In addition, the interest accrued monthly between July 1, 2022, and December 31, 2022, will be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08 per share of Common Stock in the amount of the interest accrued for each month.

12. Subsequent Events

On November 13, 2022, the Company entered into an amended and restated credit facility agreement with Thomas B. Akin, a director of the Company (the “A&R Credit Agreement”) and a corresponding convertible note in the amount of $4,466,043 (the “Convertible Note”). The A&R Credit Agreement amends and restates the current Credit Agreement and allows for the Company to borrow up to $6 million in advances. The Convertible Note accrues interest monthly at 15% per annum. Principal and accrued interest payments are due in 24 monthly installments under the Convertible Note beginning on January 31, 2023 and continuing on the last day of each of the next 23 months thereafter. The Convertible Note and all accrued interest thereon are convertible into shares of our common stock, from time to time, at the option of the holder thereof, at a conversion price per share equal to 85% of the volume-weighted average price of our common stock quoted on the OTCQB ® Venture Market operated by OTC Markets Group Inc. over the thirty (30) trading days immediately preceding such date (the “Conversion Price”). The Convertible Note and all accrued interest thereon will be automatically converted into common stock at the Conversion Price on the dated that is five business days prior to the date on which the Company becomes listed on a national securities exchange if all listing requirements have been satisfied by the Company (other than the Company satisfying any stockholders’ equity requirement to be listed on such national exchange).

The foregoing description of the A&R Credit Agreement and Convertible Note does not purport to be complete and is qualified in its entirety by reference to the A&R Credit Agreement and Convertible Note, which fill be filed separately.


15

Item 2. Management'sManagement’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statementsas defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in connection with the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially and adversely from those expressed or implied by such forward-looking statements Such forward-looking statements include statements about our expectations, beliefs or intentions regarding our potential product offerings, business, financial condition, results of operations, strategies or prospects. You can identify forward-looking statements by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends, or results as of the date they are made and are often identified by the use of words such as anticipate,believe,continue,could,estimate,expect,intend,may,or will,and similar expressions or variations. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those risks disclosed under the caption Risk Factorsincluded in our 20202022 annual report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on March30, 2021,April 3, 2023, and in our subsequent filings with the SEC. Furthermore, such forward-looking statements speak only as of the date of this report. We undertake no obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

Overview

Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized data-driven marketing campaigns.

Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to:

Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence.

Measure, predict, and boost guest frequency and spend by channel.

Deploy and manage one-time use offer codes and attribute sales accurately across every channel, promotion, and media program.

Deliver 1:1 promotions and offers with customized Mobile Messaging, Personalized Receipt Promotions, and Integrated Loyalty programs.

Mobivity’s Recurrency, delivered as a Software-as-a-Service (“SaaS”) platform, is used by leading brands including Subway, Sonic Drive-In, Baskin Robbins, Chick-fil-A and Checkers/Rally’s across more than 40,000 retail locations globally.

We’re living in a data-driven economy. By 2003 — when the concept of “Big Data” became common vernacular in marketing - the amount of data being created every two days was equal to the amount created in all of the time prior to 2003. Today, 90% of the world’s data has been created in just the past two years. Unfortunately, despite there being so much data accumulated, only one percent of data is being utilized today by most businesses.

The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems, and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. This is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks, and Yum Brands.

Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media, and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. In other words, for every dollar invested in marketing, retailers using Recurrency to manage, optimize and deliver multi-channel consumer promotions generate an average of ten dollars in incremental revenue from their customers.

18
Table of Contents

The Recurrency Platform

Mobivity’s Recurrency™ platform unlocks valuable POS and mobile data to help transform customer transactions into actionable and attributable marketing insights. Our technology provides transactional data, in real-time, that uncovers market-basket information and attributes both online and traditional promotions. Recurrency is comprised of seven components, described in detail below.

POS Data Capture

Recurrency captures, normalizes, integrates, and stores transaction data and is compatible with most POS systems used by restaurants and retailers today. The result is a clean useful dataset upon which to predict and influence customers’ buying behavior and deliver basket-level insights.

Analytics Powered by Machine Learning

Recurrency uses Machine Learning (“ML”) to uncover patterns in the buying behaviors of consumers and leverages that data to suggest pricing optimizations, and guide marketing campaigns.

Offers and Promotions

Recurrency provides a digital wallet system for creating and managing dynamic offers and promotions, enabling accurate and complete closed-loop attribution across all channels, media, and marketing efforts. Retailers can deploy one-time, limited-use, and multi-use promotions across all online and offline marketing channels that are scannable at the POS or redeemable online, enabling fraud-free, controllable promotion delivery and attribution at scale. Marketing teams can use the comprehensive attribution analysis and insights to optimize media mix and spend for maximum Return on Marketing Spend (“ROMS”).

19
16

Table of Contents

Predictive Offers

Recurrency leverages the normalized data captured at the POS and applies Artificial Intelligence (“AI”) to build profiles of both known and anonymous customers, analyzes pre and post-redemption behavior, and then predicts offers that will drive the highest increases in customer spend and frequency at the lowest discount possible. The result is optimized, personalized promotions that produce the highest ROMS possible.

Personalized Receipt Promotions

Recurrency unlocks the power of transactional data to create relevant and timely customer messages printed on the receipts already being generated at the POS. Both clients and agencies are using Recurrency to drive better results and make decisions around offers, promotions, and customer engagement through the medium of the printed receipt. Software integrated with leading POS systems, such as Oracle or MICROS, or installed directly onto receipt printer platforms, such as Epson’s OmniLink product, dynamically controls what is printed on receipts including images, coupons, announcements, or other calls-to-action, such as invitations to participate in a survey. Recurrency offers a Web-based interface where users can design receipt content and implement business rules to dictate what receipt content is printed in particular situations. All receipt content is transmitted to cloud-based Recurrency for storage and analysis.

Customized Mobile Messaging

Recurrency transforms standard short message service (“SMS”), multimedia messaging service (“MMS”), and rich communication services (“RCS”) into a data-driven marketing medium. Recurrency tracks and measures offer effectiveness at a more granular level than other solutions, allowing clients to create smarter offers and drive higher redemption rates. Our proprietary platform connects to all wireless carriers so that any consumer, on any wireless service (for example, Verizon), can join our customer’s SMS/MMS mobile marketing campaign. Our customers use Recurrency’s self-service interface to build, segment, target and optimize mobile messaging campaigns to drive increased guest frequency and spend. Recurrency is an industry leader in RCS messaging and has an industry-leading broadcast reach.

Belly Loyalty

Mobivity’s Belly Loyalty solution drives increased customer engagement and frequency with a customer-facing digital rewards platform via an app and digital pad. Using Belly, customers can customize rewards and leverage pre-built email campaigns and triggers to encourage greater frequency as well as to identify and reactivate lapsed customers.

Company Strategy

Our objective is to build an industry-leading SaaS product that connects consumers to merchants and brands. The key elements of our strategy are:

Exploit the competitive advantages and operating leverage of our technology platform. The core of our business is our proprietary POS Data Capture technology. Several years of development went into designing POS Data Capture such that the process of intercepting POS data and performing actions, such as controlling the receipt printer with receipt is scalable, portable to a wide variety of POS platforms, and does not impact performance factors including the print speed of a typical receipt printer. Furthermore, we believe the transmission of POS data to Mobivity’s cloud-based data stores presents a very competitive and innovative method of enabling POS data access. Additionally, we believe that our Recurrency platform is more advanced than technologies offered by our competitors and provides us with a significant competitive advantage. With more than ten years of development, we believe that our platform operates SMS/MMS text messaging transactions at a “least cost” relative to competitors while also being capable of supporting the SMS/MMS text messaging transactional volume necessary to serve our goal of several thousand end users. Leveraging our Recurrency platform allows for full attribution of SMS/MMS offers, which we believe is a unique combination of both SMS/MMS text messaging and POS data.

Evolve our sales and customer support infrastructure to uniquely serve very large customer implementations such as franchise-based brands that operate a large number of locations. Over the past few years, we have focused our efforts on the development of our technology and solutions with the goal of selling and supporting small and medium-sized businesses. Going forward, we intend to significantly increase our investments in sales and customer support resources tailored to selling to customers that operate franchise brands. Today we support more than 30,000 merchant locations globally.

Acquire complementary businesses and technologies. We will continue to search and identify unique opportunities which we believe will enhance our product features and functionality, revenue goals, and technology. We intend to target companies with some or all of the following characteristics: (1) an established revenue base; (2) strong pipeline and growth prospects; (3) break-even or positive cash flow; (4) opportunities for substantial expense reductions through integration into our platform; (5) strong sales teams; and (6) technology and services that further build out and differentiate our platform. Our acquisitions have historically been consummated through the issuance of a combination of our common stock and cash.

Build our intellectual property portfolio. We currently have nine issued patents that we believe have significant potential applications in the technology industry. We plan to continue our investment in building a strong intellectual property portfolio.

While these are the key elements of our current strategy, there can be no guarantees that our strategy will not change or that our strategy will be successful.

20
Table of Contents

Recent Events

Unsecured Promissory Note Investments in 20212023 Warrants Exercise

During the yearquarter ended December 31, 2021, we issued to Talkot Capital LLC, unsecured notes in the principal aggregate amount of $271,875, which are due and payable two years after issuance (the "Talkot Notes"). These Talkot Notes bear interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay the advances and accrued interest, in whole or in part, without notice, penalty, or charge.

Unsecured Promissory Note Investments in 2022

On August 13, 2022, an amendment to the Credit Facility agreement was agreed upon. The amendment updated the date to begin payment from July 31, 2022, to December 31, 2022. In addition, the interest accrued monthly between July 1, 2022, and December 31, 2022, will be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08 per share of Common Stock in the amount of the interest accrued for each month.

As of SeptemberMarch 30, 2022, The Company has a principal balance of $271,875, accrued interest of $55,530 and a total of $10,352 of interest was converted into 9,585 shares of common stock and The Company recorded a gain on settlement of interest payable of $162.

Secured Promissory Note Investments in 2021

On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $6,000,000 under this Credit Agreement amended on September 30, 2022. As of December 31, 2021, the company has drawn a total of $3,478,125 including cash in the amount of $3,206,250 and $271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility and paid a total of $200,000 toward the principal balance of the loan,

The loan is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this loan without notice, penalty, or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company's common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the "VWAP"). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP. Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. On August 13, 2022, the Lender agreed to postpone the 24-month repayment period to a later period commencing on January 31, 2022, and further agreed that interest accrued on the loan between July 1, 2022 and December 31, 2022 is to be settled in shares of the Company’s common stock.

Secured Note Investments in 2022

On June 10, 2022, The Company took a draw of an additional $500,000 under the Credit Agreement. 

On August 09, 2022 the Company took a draw of an additional $300,000 under the credit agreement.

During the nine months period ending September 30, 2022, the Company issued warrants to purchase an aggregate of 177,571 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under the Credit Agreement. The estimated aggregate fair value of the warrants issued is $73,469 using the Black-Scholes option valuation model as of September 30, 2022.

As of September 30, 2022, the Company has drawn a total of $4,078,125 including cash in the amount of $3,806,250, and $271,875 of principal and accrued interest under the above-described UP Notes which were rolled into the Credit Agreement, and we have accrued interest of $387,918. A total of $151,398 of accrued interest was settled into 140,185 shares of common stock and the Company recorded a loss on debt settlement of interest payable $2,259.

On November 13, 2022, an amendment to the Credit Facility agreement was signed. The amendment updated the payment terms to the following: "Without limiting the foregoing Section 2.3(a), Borrower shall repay the principal amount of all Advances, plus accrued interest thereon, in 24 equal monthly installments commencing on January 31, 2023, and continuing thereafter on the last day of each month (or, if such last day is not a Business Day, on the Business Day immediately preceding such last day. Interest on the unpaid Advances will accrue from the date of each Advance at a rate equal to fifteen percent (15%) per annum. Interest will be calculated on the basis of 365 days in a year." The amendment raised the maximum amount of the Credit Agreement to $6,000,000. In addition, the interest accrued monthly between July 1, 2022, and December 31, 2022, will be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08 per share of Common Stock in the amount of the interest accrued for each month.d for each month.

2022 Warrant Exercises

On February 9, 2022, 1715 warrant holders exercised their common stock purchase warrant for 3,188,1903,587,487 shares at the exercise price of $0.80$1.00 per share, resulting in additional capital of $2,550,553.$3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders 3,188,1901,793,745 new warrants to purchase common stock at $1.50$2.00 per share over a three-year period expiring in February 2025.  As an inducement for

2023 Related Party Notes Payable

On January 31, 2023, the holders' exerciseCompany entered into Amendment No. 1 (the “Amendment”) to the Amended and Restated Credit Facility Agreement and Convertible Notes which amends our existing Amended and Restated Credit Facility Agreement, dated as of November 11, 2022, between the Company and Thomas B. Akin, a director of the warrants, weCompany (the “Existing Credit Agreement” and as amended by the Amendment, the “Credit Agreement”) and any convertible notes issued thereunder. The Amendment amends the holders 3,188,190 new warrantsExisting Credit Agreement to purchase common stock at $1.50 per share overextend the maturity of the Credit Agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a three-year period expiringbeginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the Credit Agreement is to be paid quarterly in December 2023. The company recorded $382,048 of stock-based expense related to warrants issued during the warrant conversion offer on February 9, 2022. 

2022 Private Placement

In June 2022, we commenced a private placement of 1,062,500 units of our securities, at a price of $.80 per unit. Each unit consists of one shareshares of our common stock, andat a common stock purchase warrantprice per share equal to purchase one sharethe volume-weighted average price of our common stock quoted on the OTCQB® Venture Market operated by OTC Markets Group Inc. over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible note to be issued under the Credit Agreement in the future and any outstanding convertible notes issued under the Existing Credit Agreement.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, a three-year period, at an exercise pricecopy of $1.50 per share.which was filed with the SEC on the Company’s Current Report on Form 8-Kdated January 31, 2023, and is attached as Exhibit 10.1 to such Current Report on Form 8-K and incorporated herein by reference.

2023 Shares Issued

On January 31, 2023 a total of 545,012 shares were issued to John Harris, a former director. The offering was conductedshares were issued based on the total Restricted Stock Units earned by our management and no commission or other selling fees were paid by us.  Mr. Harris as director compensation.

In August 2022, we commencedOn March 27, 2023 a private placementtotal of 1,500,000 units154,106 shares of our securities, at a price of $.80 per unit. Each unit consists of one share of our common stock andwere issued to Thomas Akin as settlement of interest payable.

On March 27, 2023 a total of 9,651 shares were issued to Talkot Fund LP as settlement of interest payable.

On May 08,2023 a total of 180,715 shares of common stock purchase warrant to purchase one share of our common stock, over a three-year period, at an exercise price of $1.50 per share. The offering was conducted by our management and no commission or other selling fees were paid by us. 

As of September 30, 2022 issued 2,562,500 units under this placement.

2022 Equity Incentive Plan

On September 19, 2022, the directors of Mobivity Holdings Corp. (the “Company”) approved the Mobivity Holdings Corp. 2022 Equity Incentive Plan (the “2022 Plan”). As provided in the 2022 Plan, 12,000,000 shares of the Company’s common stock, $0.001 par value per share (“Common Stock”), are available for issuance as the subject of awards and issued to employees, consultants, and advisorsThomas Akin as settlement of the Company or any subsidiary,interest payable.

On May 08, 2023 a total of 9,441 shares were issued to Talkot Fund LP as well as non-employee directorssettlement of the Company.interest payable.

Office Relocation

We entered into a six-year office lease starting in February of 2021 for 8,898 square feet of office space located at 3133 W. Frye Road, Suite 215, Chandler, Arizona. Monthly rental payments, excluding common area maintenance charges, will be $25,953 to $28,733. The first 12 months of the lease included a 50% abatement period.

Intellectual Property

U.S. Patent number 10,949,868 B1 was granted on March 16, 2021. This patent covers the single use of electronic retailer coupons and a referral program. The method and system prevent fraud, are specific to geolocation, and provide an audit trail of the customer, cashier, and marketing platform. A user can also earn a subsequent coupon by referring a friend.

US Patent number 6,788,769 B1 expired in March of 2021. This patent covered a method and system for using telephone numbers as a key to address, email, and online content without the use of a look-up database. Using this system, a phone number is used to access a website or an email address in exactly the same way it is used to dial a telephone. 

Results of Operations

Revenues

Revenues consist primarily of those generated by a suite of products under the Recurrency platform. The Recurrency platform is comprised of POS Data Capture, Analytics, Offers and Promotions, Predictive Offers, Personalized Receipt Promotions, Customized Mobile Messaging, Belly Loyalty, and other revenues.

Revenues for the three months ended SeptemberJune 30, 2022,2023, were $1,890,437$1,861,171 a decrease of $421,111 or 18%$5,991 compared to the same period in 2021.2022.

Revenues for the ninesix months ended SeptemberJune 30, 2022,2023, were $5,787,168$3,742,653 a decrease of $1,774,798$154,078 or 23%4% compared to the same period in 2021.2022.

This decrease is primarily due to a decrease of in revenue of $421,111 quarterly due to the restructuring of customer a contract related to Smart Receipt services.subscription revenue.

21
Table of Contents

Cost of Revenues

Cost of revenues consists primarily of cloud-based software licensing fees, short code maintenance expenses, messaging-related expenses, and other expenses.

Cost of revenues for the three months ended SeptemberJune 30, 2022,2023, was $1,806,022,$1,371,206, an increase of $797,319,$168,457, or 79%14%, compared to $1,202,749 for the same period in 2021.2022.

Cost of revenues for the ninesix months ended SeptemberJune 30, 2022,2023, was $4,183,719, an increase$2,437,781, a decrease of $861,080,$60,084, or 26%3%, compared to $2,377,697 for the same period in 2021.2022.

This increase is primarily due to an increase of $50,000 in customer acquisition costs, SMS messaging costs, and MMS messaging costsapplication expense.

General and Administrative

General and administrative expenses consist primarily of salaries and personnel-related expenses, consulting costs, and other expenses.

General and administrative expenses decreased $261,657increased $173,169 or 21%,19% to $983,428,$1,071,153, during the three months ended SeptemberJune 30, 2022,2023, compared to $1,245,085$897,984 for the same period in 2021.2022. The decreaseincrease in general and administrative expenses was primarily due to a decreasean increase in legal fees.stock related expense for the warrant exercise that occurred during the period.

General and administrative expenses decreased $403,267increased $510,099 or 12%,24% to $3,088,588,$2,615,259 during the ninesix months ended SeptemberJune 30, 2022,2023, compared to $3,491,855$2,105,160 for the same period in 2021.2022. The decreaseincrease in general and administrative expenses was primarily due to a decreasean increase in legal fees.stock related expense for the warrant exercise that occurred during the period.

Sales and Marketing

Sales and marketing expenses consist primarily of salaries and personnel-related expenses, stock-based compensation expenses, consulting costs, and other expenses.

Sales and marketing expenses decreased $364,368,increased $36,641, or 37%6%, to $614,600$602,911 during the three months ended SeptemberJune 30, 2022,2023, compared to $978,968$566,270 for the same period in 2021.2022. The decreaseincrease is primarily due to reductionsand $24,000 increase in payroll expenses and share-based compensation.expense.

Sales and marketing expenses decreased $1,209,040,increased $130,360, or 40%11%, to $1,778,371$1,294,131 during the ninesix months ended SeptemberJune 30, 2022,2023, compared to $2,987,411$1,163,771 for the same period in 2021.2022. The decreaseincrease is primarily due to reductionsa $86,000 increase in payroll expenses and share-based compensation.payroll.

22
17

Table of Contents

Engineering, Research & Development

Engineering, research & development costs include salaries, stock-based compensation expenses, travel, consulting costs, and other expenses.

Engineering, research & development expenses increased $106,595,decreased $69,493, or 16%8%, to $784,804$804,343 during the three months ended SeptemberJune 30, 2022,2023, compared to $678,209$873,836 for the same period in 2021.2022. This increasedecrease is primarily due to the enda decrease of the ASC 606 deduction, an increase$76,000 in payroll and an increase in professional services.expense.

Engineering, research & development expenses increased $284,669,decreased $37,341, or 14%2%, to $2,360,863$1,538,718 during the ninesix months ended SeptemberJune 30, 2022,2023, compared to $2,076,194$1,576,059 for the same period in 2021.2022. This increasedecrease is primarily due to the end of the ASC 606 deduction, an increasea $62,000 decrease in payroll and an increase in professional services.expenses.

Impairment on Intangible Asset

Impairment on intangible assets consists of an intangible asset valued at less than its carrying value.

Impairment on intangible assets increased 100% from $0 to $238,143 for the three months ended September 30, 2022, compared to the same period in 2021 The increase is a result of the impairment analysis performed.

Impairment on intangible assets increased from $8,286 to $238,143 for the nine months ended September 30, 2022, compared to the same period in 2021. The increase is a result of the impairment analysis performed.

Depreciation and Amortization

Depreciation and amortization expenses consist of depreciation on our equipment and amortization of our intangible assets.

Depreciation and amortization expense decreased $73,389 or 67%, to $36,582 during the three months ended June 30, 2023 compared to $110,421 for the same period in 2022.This decrease is primarily due to decrease in intangible assets due to impairment at the end of 2022.

Depreciation and amortization expenses decreased $64,346$134,249 or 35%57%, to $118,317$100,484 during the threesix months ended SeptemberJune 30, 20222023 compared to $182,663$234,733 for the same period in 2021.2022. This decrease is primarily due to decrease in intangible assets due to impairment at the reduction in amortizationend of intangibles on software development costs.2022.

Depreciation and amortization expenses decreased $171,424Interest Expense

Interest expense increased $77,317, or 33%46%, to $353,050 during the nine months ended September 30, 2022 compared to $524,474 for the same period in 2021. This decrease is primarily due to the reduction in amortization of intangibles on software development costs.

Interest Income

Interest income consists of stated interest income on our cash balances. Interest income was $0$244,443 during the three months ended SeptemberJune 30, 2022,2023, compared to the same period in 2021. 

Interest income consists of stated interest income on our cash balances. Interest income decreased $5 or 100% to $0, during the nine months ended September 30, 2022, compared to the same period in 2021. 

Interest Expense

Interest expense consists of stated or implied interest expense on our notes payable, amortization of note discounts, and amortization of deferred financing costs.

Interest expense increased $105,170, or 119%, to a total of $193,501 during the three months ended September 30, 2022, from compared to $88,331$167,126 in the same period in 2021.2022. This increase in interest expense is primarily related to the new line of credit taken out in 2021.increased balance on related party notes payable.

Interest expense increased $375,740,$155,936 or 260%48%, to a total of $520,454$482,889 during the ninesix months ended SeptemberJune 30, 2022,2023, compared to $144,714$326,953 in the same period in 2021.2022. This increase in interest expense is primarily related to anthe increase in borrowings from ourbalance on related parties.party notes payable.

Gain on ForgivenessSettlement Losses

Settlement losses consist of Debtlegal settlement for TCPA settlements.

On July 21, 2021, SBA authorized full forgiveness of the $891,103 PPP Loan after the Company applied for loan forgiveness and met all the requirements for such loan forgiveness under the SBA program. The balance of the loan was forgiven and recorded as a gain on forgiveness of debt of $891,103. Gain on forgiveness of debt decrease 100% to $0Settlement losses for the three and nine month periodssix months ended SeptemberJune 30, 20222023 were $2,500 and $12,500, respectively. There were no settlement losses for the three and six months ended June 30, 2022.

Loss on DisposalSettlement of Fixed AssetsDebt

TheLoss on Settlement of debt consists of the expense from the settlement of notes payable when they are settled into shares.

Loss on settlement of debt for the three and six months ended June 30, 2023 was $0 and $10,857, respectively. There was no loss on disposalsettlement of assets decreased by 100% from a Septemberdebt for the three and six months ended June 30, 2021, balance of  $880 to a September 30, 202, balance of $0.2022.

Foreign Currency

The Company’s financial results are impacted by volatility in the Canadian/U.S. Dollar exchange rate. The average U.S. Dollar exchange rate for the three and ninesix months ended SeptemberJune 30, 2022,2023, was $1 Canadian equals $0.78$0.74 U.S. Dollars. This compares to an average rate of $1 Canadian equals $0.79 during the same period in 2021.2022. The Company’s functional or measurement currency is the U.S. Dollar. Based on a U.S. Dollar functional currency, the following are the key areas impacted by foreign currency volatility:

The Company sells products primarily in U.S. Dollars; therefore, reported revenues are not highly impacted by foreign currency volatility.

A portion of the Company’s expenses are incurred in Canadian Dollars and therefore fluctuate in U.S. Dollars as the U.S. Dollar varies. A weaker U.S. Dollar results in an increase in translated expenses, and a stronger U.S. Dollar results in a decrease.

Changes in foreign currency rates also impact the translated value of the Company’s working capital that is held in Canadian Dollars. Foreign exchange rate fluctuations result in foreign exchange gains or losses based upon movement in the translated value of Canadian working capital into U.S. Dollars.

The change in foreign currency was a loss of $76,228$137 and a loss of $13,150$12,261 for the three months ended SeptemberJune 30, 2023 and 2022, and 2021, respectively.

The change in foreign currency was a lossgain of $76,862$31,365 and a loss of $22,391$634 for the ninesix months ended SeptemberJune 30, 2023 and 2022, and 2021, respectively.

Liquidity and Capital Resources

As of SeptemberJune 30, 2022,2023, we had current assets of $2,139,214,$1,495,553, including $1,016,745$529,471 in cash, and current liabilities of $7,228,819,$6,349,447, resulting in a working capital deficit of $5,089,605.$4,853,894.

We believe as of the date of this report, we do not have the working capital on hand, along with our expected cash flow from operations and budget reductions, to sufficiently fund our current level of operations through the end of the next 12 months or beyond. We will require additional capital and will seek to obtain additional working capital through the sale of our securities and, if available, bank lines of credit. There can be no assurance we will be able to obtain access to capital as and when needed, or that the terms of any available financing will be commercially reasonable.

23
Table of Contents

18

Cash Flows

 

Nine Months Ended

  Six Months Ended 
 

September 30,

  June 30, 
 

2022

 

2021

  2023  2022 

Net cash provided by (used in):

         

Operating activities

 $(4,966,359) $(3,189,511) $(3,486,777) $(3,519,680)

Investing activities

 (30,742) (388,763)  (14,111)  (6,993)

Financing activities

 5,371,407  886,076   3,570,803   3,884,164 

Effect of foreign currency translation on cash flow

  (92,985)  (21,726)  32,816   (1,895)

Net change in cash

 $281,321  $(2,713,924) $102,731  $356,036 

Operating Activities

We used cash fromin operating activities totaling $ 4,966,359$3,486,777 during the ninesix months ended SeptemberJune 30, 20222023 and used cash fromin operating activities totaling $ 3,189,511during$3,519,680 during the ninesix months ended SeptemberJune 30, 2021. 2022. Key drivers of the cash used in operating activities are the net loss of $4,750,257 and changes to accounts receivable of $539,017, other current assets (notably prepaid expenses) of $228,732, accrued interest of $410,644, accrued and deferred personnel compensation of $272,193, and deferred revenue and customer deposits of $432,977.

Investing Activities

Investing activities during the ninesix months ended SeptemberJune 30, 2022,2023, consisted of $18,712$14,111 of equipment purchases and $12,030 of capitalized software development costs.

Investing activities duringcompared to $6,993 in the ninesix months ended SeptemberJune 30, 2021, consisted of $78,217 of equipment purchases and $310,546 of capitalized software development costs.2022.

Financing Activities

Financing activities during the ninesix months ended SeptemberJune 30, 2022,2023, consisted of $2,550,552 additional paid-in capitalproceeds of $3,587,487 from a warrant conversion to common stock, $2,050,000 additional paid-in capitalproceeds of $210,045 from two private placement financings, $800,000issuance of common stock for conversion of interest payable on related party debt and $16,684 in payments on notes payable. Financing activities during the six months ended June 30, 2022, consisted of $3,400,551 in proceeds forfrom a warrant conversion to common stock and a PIPE funding, $500,000 in proceeds from related party notes payable and $29,145$16,684 in paymentpayments on notes payable.

Critical Accounting Policies and Estimates

Refer to Note 2, “Summary of Significant Accounting Policies,” in the accompanying notes to the condensed consolidated financial statements for a discussion of recent accounting pronouncements.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

We are a smaller reporting company as defined by Item 10(f)(1) of Regulation S-K. As such, we are not required to provide the information set forth in this item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. "Disclosure“Disclosure controls and procedures,” as defined in Exchange Act Rule 13a-15(e), are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, , including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that as of SeptemberJune 30, 20222023 our disclosure controls and procedures were not effective.

As a small company with limited resources that are mainly focused on the development and sales of software products and services, the Company does not employ a sufficient number of staff in its finance department to possess an optimal segregation of duties or to provide optimal levels of oversight. This has resulted in certain audit adjustments and management believes that there may be a possibility for a material misstatement to occur in future periods while it employs the current number of personnel in its finance department.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, that occurred during the ninesix months ended SeptemberJune 30, 20222023 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

24
19

Table of Contents

PART II OTHER INFORMATION

Item 1. Legal Proceedings.


None. From time

The Company had a legal proceeding related to time, we may become involvedTCPA (Telephone Consumer Protection Act) Violation. This is a putative class action complaint alleging that Defendant initiated telephone solicitations through text messages in legal proceedings or be subjectviolation of the Florida Telephone Solicitation Act, Fla. Stat. §501.059 (“FTSA”). The defense of the matter was tendered to the Company by its client, Sonic Industries, Inc. During the six months ended June 30, 2023, the Company has settled four TCPA claims arising infor a total settlement loss of $12,500 and this amount is included within settlement losses on the ordinary courseaccompanying unaudited consolidated statements of our business. We are not currently a party to any material legal proceedings.operations and comprehensive loss.

Item 1A. Risk Factors.

We are a smaller reporting company, as defined by Item 10(f)(1) of Regulation S-K. As such, we are not required to provide the information set forth in this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

OnDuring the six months ended June 29, 2022, we sold 1,062,500 shares of30, 2023, 15 warrant holders exercised their common stock andpurchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders 1,793,745 new warrants to purchase up to 1,062,500 additional shares of common stock for an aggregate offering price of $849,999. The warrants are exercisable forat $2.00 per share over a three-year period of three years from the date of issuance at an initial exercise price of $1.50 per share.expiring in February 2025.

On August 24, 2022, we sold 1,250,000 shares of common stock and warrants to purchase up to 1,250,000 additional shares of common stock for an aggregate offering price of $1,000,000. The warrants are exercisable for a period of three years from the date of issuance at an initial exercise price of $1.50 per share.

For the foregoing warrants, the exercise price of the warrant and the number of the shares issuable upon exercise of the warrant are subject to customary adjustments prior to exercise upon the occurrence of certain events affecting all outstanding shares of common stock.

The foregoing securities were issued in reliance on an exemption from registration set forth in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) to a limited number of persons who were “accredited investors,” as defined in Rule 501 of Regulation D of the Securities Act, without the use of any general solicitations or advertising to market or otherwise offer the securities for sale. None of the shares, warrants or shares of common stock issued upon exercise of the warrants have been registered under the Securities Act or applicable state securities laws and none may be offered or sold in the United States absent registration under the Securities Act, or an exemption from such registration requirements. Neither this quarterly report on Form 10-Q nor any exhibit attached hereto shall constitute an offer to sell or the solicitation of an offer to buy any securities.

Item 3. Defaults upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information
 

The information set forth below is included herein for purposes of providing the disclosure required under “Item 1.01 Entry Into a Material Definitive Agreement; Item 2.03 Creation3.02 Unregistered Sales of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Equity Securities.” of Form 8-K.

On November 13, 2022,August 7, 2023, the Company entered into an amendedannounced a warrant exercise inducement and restated credit facility agreement withwarrant offering (the “Offer to Amend and Exercise”), providing the holders of certain warrants (the “Old Warrants”), including Thomas B. Akin, a director of the Company, (the “A&R Credit Agreement”with an opportunity to exercise their Old Warrants at a reduced exercise price of $0.82 per share and to receive a new warrant (“New Warrant”) and a corresponding convertible note in the amount of $4,466,043 (the “Convertible Note”). The A&R Credit Agreement amends and restates the current Credit Agreement and allows for the Company to borrow up to $6 million in advances. The Convertible Note accrues interest monthly at 15% per annum. Principal and accrued interest payments are due in 24 monthly installments under the Convertible Note beginning on January 31, 2023 and continuing on the last day of each of the next 23 months thereafter. The Convertible Note and all accrued interest thereon are convertible intopurchase two shares of our common stock, $0.001 par value (“Common Stock”) for every one share of our Common Stock that the holder purchases upon the exercise of an Old Warrant (at the reduced $0.82 per share exercise price). The New Warrants will be exercisable for a period of three years from time to time,the date of issuance at the optionan initial exercise price of $0.82 per share. The exercise price of the holder thereof, at a conversion price per share equal to 85%New Warrants and the number of the volume-weighted average priceshares issuable upon exercise of our common stock quoted on the OTCQB ® Venture Market operated by OTC Markets Group Inc. over the thirty (30) trading days immediately preceding such date (the “Conversion Price”). The Convertible Note and all accrued interest thereon will be automatically converted into common stock at the Conversion Price on the dated that is five business daysNew Warrants are subject to customary adjustments prior to exercise upon the dateoccurrence of certain events affecting all outstanding shares of Common Stock. The Offer to Amend and Exercise will expire at 5:00 p.m. Eastern time on whichSeptember 6, 2023.

The shares of Common Stock issued upon exercise of the Company becomes listedOld Warrants (the “Shares”) and the New Warrants are to be issued in reliance on an exemption from registration set forth in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) to a nationallimited number of persons who are “accredited investors,” as defined in Rule 501 of Regulation D of the SEC, without the use of any general solicitations or advertising to market or otherwise offer the securities exchange if all listing requirementsfor sale. None of the Shares, New Warrants or shares of Common Stock issued upon exercise of the New Warrants have been satisfied byregistered under the Company (other thanSecurities Act or applicable state securities laws and none may be offered or sold in the Company satisfyingUnited States absent registration under the Securities Act, or an exemption from such registration requirements. Neither this Quarterly Report on Form 10-Q nor any stockholders’ equity requirementexhibit attached hereto shall constitute an offer to be listed on such national exchange).

In addition, in connection withsell or the executionsolicitation of an offer to buy the Shares, the New Warrants or any other securities of the A&R Credit Agreement and the Convertible Note, the Company issued Mr. Akin 140,185 shares of common stock on November 14, 2022.Company.

The foregoing descriptiondescriptions of the A&R Credit AgreementOffer to Amend and Convertible Note does not purport to be completeExercise and isNew Warrants are qualified in its entirety by reference to the A&R Credit Agreementfull text of the form of Exercise Notice and Convertible Note,form of New Warrant, which fill beare filed separately.


as Exhibits 10.6 and 10.7, respectively, to this Quarterly Report on Form 10-Q and are incorporated herein by reference.

[A1]Note to Company: To confirm this is accurate.

25
Table of Contents

Item 6. Exhibits

Exhibit No.Description

Exhibit No.

Description

3.110.1 Amended and Restated Articles of Incorporation filed with the Nevada Secretary of State on August 12, 2022*Credit Facility Agreement *
3.210.2 Bylaws (1)Convertible Note *
3.310.3Amendment No. 1 to the Bylaws, effectiveAmended and Restated Credit Facility Agreement and Convertible Notes, dated as of November 25, 2011 (2)January 31, 2023, between Mobivity Holdings Corp. and Thomas B. Akin *

31.1

10.4

Form of Exercise Notice for Offer to Amend and Exercise completed March 16, 2023 *

10.5Form of New Warrant issued March 16, 2023 *
10.6Form of Exercise Notice for Offer to Amend and Exercise completed August 07,2023 *
10.7Form of New Warrant issued August 07, 2023 *
31.1Certification by Chief Executive Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002 *

31.2

Certification by Chief Financial Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002 *

32.1

Certification Pursuant to 18 U.S.C. Section 1350 *

101.INS

Inline XBRL Instance Document *

101.SCH

Inline XBRL Taxonomy Schema Document

101.CAL

Inline XBRL Taxonomy Calculation Linkbase Document *

101.DEF

Inline XBRL Taxonomy Definition Linkbase Document *

101.LAB

Inline XBRL Taxonomy Label Linkbase Document*

101.PRE

Inline XBRL Taxonomy Presentation Linkbase Document *

104Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

* Filed electronically herewith

(1)                         Incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on October 20, 2008, File No. 333-154455

26
Table of Contents

(2)                         Incorporated by reference to the Company’s Current Report on Form 8-K filed December 2, 2011SIGNATURES

20

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

Mobivity Holdings Corp.

Date: NovemberAugust 14, 2022

2023

By:

/s/ Dennis Becker

Dennis Becker

Chairman and Chief Executive Officer

(Principal Executive Officer)

Date: NovemberAugust 14, 2022

2023

By:

/s/ Lisa BrennanWill Sanchez

Lisa Brennan

Will Sanchez

Chief Financial Officer

(Principal Accounting Officer)

27

21